Sulfadoxine‑Pyrimethamine + Dihydroartemisinin Tablets are an artemisinin‑based combination therapy (ACT) for the treatment of acute uncomplicated malaria.
This combination brings together:
Dihydroartemisinin: A fast‑acting artemisinin derivative that rapidly reduces parasite load and relieves clinical symptoms.
Sulfadoxine‑Pyrimethamine: A long‑acting antifolate combination that eliminates remaining parasites and prevents recrudescence.
The synergistic effect ensures high cure rates and helps delay the development of antimalarial drug resistance.
Indications
For the treatment of acute uncomplicated malaria caused by Plasmodium falciparum (including chloroquine‑resistant strains) and Plasmodium vivax in adults and children.
Key Features
Rapid parasite clearance and fast symptom relief
Long‑acting component improves cure rate and reduces relapse
Effective against many drug‑resistant malaria strains
Convenient oral tablet formulation
Good tolerability profile
Manufactured under GMP standards
Complies with international pharmacopoeial requirements
Full dossiers available for registration in malaria‑endemic countries
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
Contraindicated in patients with hypersensitivity to any component
Use with caution in patients with hepatic or renal impairment
Not recommended in severe malaria
Should be used under medical supervision
Product Description
Meta Description:
